Rabeprazole Sodium Delayed-release
NDC 72834-210
Product Information
Rabeprazole Sodium Delayed-release is a NDA AUTHORIZED GENERIC-approved product labeled by Sarras Health, Llc. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a yellow product. This product entry covers the primary NDC 72834-210 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
WHITE (C48325 - OPAQUE)
ACX;10MG
Code Structure Chart
Product Details
What is NDC 72834-210?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- RABEPRAZOLE SODIUM (UNII: 3L36P16U4R)
- RABEPRAZOLE (UNII: 32828355LL) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- DIACETYLATED MONOGLYCERIDES (UNII: 5Z17386USF)
- ETHYLCELLULOSES (UNII: 7Z8S9VYZ4B)
- HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)
- HYPROMELLOSE PHTHALATE (24% PHTHALATE, 55 CST) (UNII: 87Y6436BKR)
- MAGNESIUM OXIDE (UNII: 3A3U0GI71G)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MANNITOL (UNII: 3OWL53L36A)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- CARRAGEENAN (UNII: 5C69YCD2YJ)
- POTASSIUM CHLORIDE (UNII: 660YQ98I10)
- FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1483318 - RABEprazole sodium 10 MG Delayed Release Oral Granules
- RxCUI: 1483318 - rabeprazole sodium 10 MG Oral Granules
- RxCUI: 1483318 - rabeprazole sodium 10 MG Delayed Release Oral Sprinkle Capsule
* Please review the full disclaimer at the bottom of this page.
Patient Education
Rabeprazole
Rabeprazole is used to treat the symptoms of gastroesophageal reflux disease (GERD), a condition in which backward flow of acid from the stomach causes heartburn and possible injury of the esophagus (the tube that connects the throat and stomach) in adults and children 12 year of age and older. Rabeprazole is used to treat damage from GERD, allow the esophagus to heal, and prevent further damage to the esophagus in adults. Rabeprazole is also used to treat conditions in which the stomach produces too much acid, such as Zollinger-Ellison syndrome in adults. Rabeprazole is used to treat ulcers (sores in the lining of the stomach or intestine) and is used in combination with other medications to eliminate H. pylori (a bacteria that causes ulcers) in adults. Rabeprazole is in a class of medications called proton-pump inhibitors. It works by decreasing the amount of acid made in the stomach.
[Learn More]
* Please review the full disclaimer at the bottom of this page.